|Bid||0.4313 x 1000|
|Ask||0.4700 x 800|
|Day's range||0.4313 - 0.4563|
|52-week range||0.4200 - 1.7900|
|Beta (5Y monthly)||3.66|
|PE ratio (TTM)||N/A|
|Earnings date||27 Oct 2022 - 31 Oct 2022|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
POTOMAC, Md., September 21, 2022--IGC Announces Issuance of Second Patent for the Treatment of Alzheimer’s Using THC.
POTOMAC, Md., September 12, 2022--IGC announces that at its ASM on Sep 9'22 all proposals as disclosed on the DEF 14A were passed by the requisite stockholders vote.
POTOMAC, Md., August 08, 2022--IGC announces its financial results for the three months ended June 30, 2022, which is the first quarter of the Company’s 2023 fiscal year.